Phenindamine

Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Phenindamine
Clinical data
AHFS/Drugs.comMicromedex Detailed Consumer Information
Pregnancy
category
  • US: N (Not classified yet)
ATC code
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC19H19N
Molar mass261.361 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

WikiDoc Resources for Phenindamine

Articles

Most recent articles on Phenindamine

Most cited articles on Phenindamine

Review articles on Phenindamine

Articles on Phenindamine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Phenindamine

Images of Phenindamine

Photos of Phenindamine

Podcasts & MP3s on Phenindamine

Videos on Phenindamine

Evidence Based Medicine

Cochrane Collaboration on Phenindamine

Bandolier on Phenindamine

TRIP on Phenindamine

Clinical Trials

Ongoing Trials on Phenindamine at Clinical Trials.gov

Trial results on Phenindamine

Clinical Trials on Phenindamine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Phenindamine

NICE Guidance on Phenindamine

NHS PRODIGY Guidance

FDA on Phenindamine

CDC on Phenindamine

Books

Books on Phenindamine

News

Phenindamine in the news

Be alerted to news on Phenindamine

News trends on Phenindamine

Commentary

Blogs on Phenindamine

Definitions

Definitions of Phenindamine

Patient Resources / Community

Patient resources on Phenindamine

Discussion groups on Phenindamine

Patient Handouts on Phenindamine

Directions to Hospitals Treating Phenindamine

Risk calculators and risk factors for Phenindamine

Healthcare Provider Resources

Symptoms of Phenindamine

Causes & Risk Factors for Phenindamine

Diagnostic studies for Phenindamine

Treatment of Phenindamine

Continuing Medical Education (CME)

CME Programs on Phenindamine

International

Phenindamine en Espanol

Phenindamine en Francais

Business

Phenindamine in the Marketplace

Patents on Phenindamine

Experimental / Informatics

List of terms related to Phenindamine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Phenindamine (Nolahist, Thephorin) is an antihistamine and anticholinergic closely related to cyproheptadine. It was developed by Hoffman-La Roche in the late 1940s.[1] It is used to treat symptoms of the common cold and allergies, such as sneezing, itching, rashes, and hives. Its efficacy against some symptoms of opioid withdrawal was researched in the 1950s and 1960s in a number of countries; William S. Burroughs' book Junkie mentions this technique. Like many other first-generation antihistamines, phenindamine has useful potentiating effects on many narcotic analgesics and is even more useful with those opioids which release histamine when in the body.

Nolahist was originally manufactured in the USA by Carnrick Laboratories, and later by Amarin Pharmaceuticals. When that company ceased its American operations, its product line was acquired by Valeant, but they declined to resume manufacturing Nolahist. The last produced lot bore an expiration date of 10/2005, and the product is no longer available.

See also

References

  1. US Patent 2546652 - Pyridindenes and process for their manufacture

Template:Respiratory-system-drug-stub